Single Dose Study in Healthy Subjects
Showing 1 - 25 of >10,000
Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)
Not yet recruiting
- Healthy Adult Subjects
- ID110521156
- Placebo of ID110521156
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 26, 2023
Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)
Not yet recruiting
- Healthy
- Test (T) Bilastine
- Reference (R) Bilastine
- (no location specified)
Oct 19, 2023
Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)
Completed
- Healthy Volunteer
- GFH312 100 mg
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))
Not yet recruiting
- Alopecia Areata
- OR-101 (Single ascending dose)
- +3 more
-
Randwick, New South Wales, AustraliaSCIENTIA Clinical Research Ltd
Sep 13, 2023
Healthy Male Subjects Trial in Shanghai ([14C] Yiqibuvir)
Not yet recruiting
- Healthy Male Subjects
- [14C] Yiqibuvir
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Aug 16, 2023
Influenza, Human Trial in Shanghai (ZX-7101A, Placebo)
Not yet recruiting
- Influenza, Human
- ZX-7101A
- Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jul 20, 2023
T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)
Completed
- T2DM (Type 2 Diabetes Mellitus)
- HSK7653
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 1, 2023
Systemic Lupus Erythematosus (SLE) Trial in China (SG301 SC Injection)
Recruiting
- Systemic Lupus Erythematosus (SLE)
- SG301 SC Injection
-
Bengbu, Anhui, China
- +9 more
Nov 17, 2023
NASH With Fibrosis Trial ([14C]-rencofilstat 225mg)
Not yet recruiting
- NASH With Fibrosis
- [14C]-rencofilstat 225mg
- (no location specified)
Feb 21, 2023
Healthy Subjects Trial in Melbourne (ISM5411, Placebo)
Not yet recruiting
- Healthy Subjects
- ISM5411
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network
Aug 22, 2023
Malignant Tumor Trial (SHR2554 tablet dosing, Omeprazole tablet dosing)
Not yet recruiting
- Malignant Tumor
- SHR2554 tablet dosing
- Omeprazole tablet dosing
- (no location specified)
Oct 17, 2023
Pharmacokinetic Trial in Changchun (Lanifibranor)
Active, not recruiting
- Pharmacokinetic
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 13, 2023
Healthy Trial in Beijing (STSA-1201 Subcutaneous injection, Placebo)
Recruiting
- Healthy
- STSA-1201 Subcutaneous injection
- Placebo
-
Beijing, Beijing, ChinaBeijing Shijitan Hospital, Capital Medical University
Aug 10, 2023
Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)
Not yet recruiting
- Healthy Volunteers
- AP31969
- Placebo
-
Copenhagen, DenmarkAcesion Pharma
Sep 27, 2023
Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®
Recruiting
- Acromegaly
- SYHX2008 injection
- +3 more
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Mar 13, 2023
Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))
Not yet recruiting
- Healthy Men
- BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
-
Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023
Healthy Trial in Austin (Rodatristat Ethyl, Placebo)
Completed
- Healthy
- Rodatristat Ethyl
- Placebo
-
Austin, TexasPPD Development
Jan 25, 2023
Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)
Recruiting
- Healthy Volunteers
- SIM0278 Injection/Placebo
-
Qingdao, China, Shandong, ChinaAffiliated Hospital of Qingdao University
Aug 31, 2023
Healthy Subjects Trial in Shanghai (Part A ABSK201 and Itraconazole, Part A ABSK201 and Rifampicin)
Enrolling by invitation
- Healthy Subjects
- Part A ABSK201 and Itraconazole
- Part A ABSK201 and Rifampicin
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Oct 12, 2023